|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07J 9/00 | (2006.01) |
| C07J 51/00 | (2006.01) | ||
| A61K 9/20 | (2006.01) | ||
| A61K 31/575 | (2006.01) |
| (11) | Number of the document | 3336097 |
| (13) | Kind of document | T |
| (96) | European patent application number | 17202916.7 |
| Date of filing the European patent application | 2013-06-17 | |
| (97) | Date of publication of the European application | 2018-06-20 |
| (45) | Date of publication and mention of the grant of the patent | 2020-08-19 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 201261661531 P | 2012-06-19 | US |
| (72) |
STEINER, André, DE
WAENERLUND POULSEN, Heidi, DK
JOLIBOIS, Emilie, GB
REWOLINSKI, Melissa, US
GROSS, Ralf, DE
SHARP, Emma, GB
DUBAS-FISHER, Fiona, GB
EBERLIN, Alex, GB
|
| (73) |
Intercept Pharmaceuticals, Inc.,
10 Hudson Yards, 37th Floor, New York, NY 10001,
US
|
| (54) | PREPARATION OF THE NON-CRYSTALLINE FORM OF OBETICHOLIC ACID |
| PREPARATION OF THE NON-CRYSTALLINE FORM OF OBETICHOLIC ACID |